Greater Cannabis Company Inc

PINK:GCAN USA Drug Manufacturers - Specialty & Generic
Market Cap
$630.18
Market Cap Rank
#48694 Global
#14943 in USA
Share Price
$0.00
Change (1 day)
+16.67%
52-Week Range
$0.00 - $0.00
All Time High
$0.37
About

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, … Read more

Greater Cannabis Company Inc (GCAN) - Total Assets

Latest total assets as of September 2025: $21.36K USD

Based on the latest financial reports, Greater Cannabis Company Inc (GCAN) holds total assets worth $21.36K USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Greater Cannabis Company Inc - Total Assets Trend (2015–2024)

This chart illustrates how Greater Cannabis Company Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Greater Cannabis Company Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Greater Cannabis Company Inc's total assets of $21.36K consist of 99.3% current assets and 0.7% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 99.3%
Accounts Receivable $0.00 0.0%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $417.00 0.7%
Goodwill $0.00 0.0%

Asset Composition Trend (2015–2024)

This chart illustrates how Greater Cannabis Company Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Greater Cannabis Company Inc's current assets represent 99.3% of total assets in 2024, an increase from 0.0% in 2015.
  • Cash Position: Cash and equivalents constituted 99.3% of total assets in 2024, up from 0.0% in 2015.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 100.0% in 2015.
  • Asset Diversification: The largest asset category is intangible assets at 0.7% of total assets.

Greater Cannabis Company Inc Competitors by Total Assets

Key competitors of Greater Cannabis Company Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Greater Cannabis Company Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.64

Lower asset utilization - Greater Cannabis Company Inc generates 0.00x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -79916.11% - 0.00%

Negative ROA - Greater Cannabis Company Inc is currently not profitable relative to its asset base.

Greater Cannabis Company Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.02 0.07 0.35
Quick Ratio 0.02 0.07 0.35
Cash Ratio 0.00 0.00 0.00
Working Capital $-1.11 Million $ -798.59K $ -300.20K

Greater Cannabis Company Inc - Advanced Valuation Insights

This section examines the relationship between Greater Cannabis Company Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -66.5%
Total Assets $57.78K
Market Capitalization $614.78 USD

Valuation Analysis

Below Book Valuation: The market values Greater Cannabis Company Inc's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Greater Cannabis Company Inc's assets decreased by 66.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Greater Cannabis Company Inc (2015–2024)

The table below shows the annual total assets of Greater Cannabis Company Inc from 2015 to 2024.

Year Total Assets Change
2024-12-31 $57.78K -66.46%
2023-12-31 $172.28K -38.57%
2022-12-31 $280.45K -28.63%
2021-12-31 $392.94K +118.15%
2020-12-31 $180.12K +242.03%
2019-12-31 $52.66K -64.81%
2018-12-31 $149.64K +14969.49%
2017-12-31 $993.00 --
2016-12-31 $0.00 --
2015-12-31 $100.00K --